Scholars Central

Mini reviewPublished 27 Jun 2018

Pharmacogenomics and Personalized Medicine in the Treatment of Monogenic Diabetes

Authors: Sahu T, Bharti SN

Reports in Endocrine Disorders: Open Access

Volume 2 · Issue 1 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Monogenic diabetes was identified as a separate domain of diabetes, which is a rather generic representation of diseases characterized by hyperglycemia. It was then indicated that the differential diagnosis of such conditions is based on the genetic testing of the patients as well as identification of the specific gene that is mutated. The concept of integrative application of pharmacogenomics and personalized medicine for its treatment was proposed after the realization of the fact that the pathophysiology and therapeutic efficacy of the subsequent treatment methods depend upon the gene which is mutated. The article presents a concise overview of the need of research and development of personalized medicine based approaches for the treatment of monogenic diabetes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalReports in Endocrine Disorders: Open Access
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Sahu T”
  • BylineArticles whose byline prints “Bharti SN”